SE7908701L - Difenyl-dibutylpiperazinkarboxamider - Google Patents

Difenyl-dibutylpiperazinkarboxamider

Info

Publication number: SE7908701L
Authority: SE; Sweden
Prior art keywords: dibutylpiperazinkarboxamider; diphenyl; diphenyl dibutylpiperazinkarboxamider
Prior art date: 1978-10-20

Application number

SE7908701A

Other languages

Unknown language ( )

English (en)

Other versions

SE448730B (sv

Inventor

A K K Bjork

K G Olsson

A L Abramo

E G Christensson

Original Assignee

Ferrosan Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-10-20

Filing date

1979-10-19

Publication date

1980-04-21

1979-10-19 Application filed by Ferrosan Ab filed Critical Ferrosan Ab

1980-04-21 Publication of SE7908701L publication Critical patent/SE7908701L/sv

1987-03-16 Publication of SE448730B publication Critical patent/SE448730B/sv

Links

ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 title 2
235000010290 biphenyl Nutrition 0.000 title 1
239000004305 biphenyl Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/194—Radicals derived from thio- or thiono carboxylic acids
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L1/00—Enclosures; Chambers
- B01L1/52—Transportable laboratories; Field kits

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)

SE7908701A 1978-10-20 1979-10-19 Nya 1-(4,4-difenylbutyl)piperazin-karboxamider och karbotioamider samt anvendning av dessa foreningar for framstellning av medel for behandling av vissa sjukdomstillstand SE448730B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE7810971		1978-10-20

Publications (2)

Publication Number	Publication Date
SE7908701L true SE7908701L (sv)	1980-04-21
SE448730B SE448730B (sv)	1987-03-16

Family

ID=20336152

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7908701A SE448730B (sv)	1978-10-20	1979-10-19	Nya 1-(4,4-difenylbutyl)piperazin-karboxamider och karbotioamider samt anvendning av dessa foreningar for framstellning av medel for behandling av vissa sjukdomstillstand

Country Status (21)

Country	Link
US (3)	US4308387A (sv)
JP (1)	JPS5557572A (sv)
AT (1)	AT376666B (sv)
AU (1)	AU529260B2 (sv)
BE (1)	BE879528A (sv)
CA (1)	CA1130807A (sv)
CH (1)	CH643247A5 (sv)
DE (1)	DE2941880A1 (sv)
DK (1)	DK149057C (sv)
ES (1)	ES485188A1 (sv)
FI (1)	FI73986C (sv)
FR (1)	FR2439187A1 (sv)
GB (1)	GB2037745B (sv)
HK (1)	HK57184A (sv)
IT (1)	IT1207269B (sv)
LU (1)	LU81807A1 (sv)
NL (2)	NL190160C (sv)
NO (1)	NO154582C (sv)
NZ (1)	NZ191867A (sv)
SE (1)	SE448730B (sv)
SG (1)	SG7384G (sv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE791501A (fr) *	1971-11-19	1973-05-17	Albert Ag Chem Werke	Diamines cycliques n,n'-disubstituees et leur procede de preparation
WO1981003658A1 (en) *	1980-06-16	1981-12-24	Ferrosan Ab	Diphenylbutyl-1-acylpiperazines
ATE28327T1 (de) *	1981-12-02	1987-08-15	Ferrosan Ab	1-piperazinocarboxylate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4543352A (en) *	1983-04-29	1985-09-24	William H. Rorer, Inc.	Naphthalene aminoalkylene ethers and thioethers, and their pharmaceutical uses
AT387572B (de) *	1983-05-20	1989-02-10	Ferrosan Ab	Verfahren zur herstellung von neuen 4-(4,4-bis-(p-fluorphenyl)-butyl)-1-carbophenox -piperazinen und von 1-piperazincarboxamiden
ES524680A0 (es) *	1983-08-02	1984-12-16	Espanola Farma Therapeut	Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
SE8304361D0 (sv) *	1983-08-10	1983-08-10	Ferrosan Ab	Novel 1-acylpiperazine derivatives novel 1-acylpiperazine derivatives
FR2558162B1 (fr) *	1984-01-17	1986-04-25	Adir	Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
SE8500573D0 (sv) *	1985-02-08	1985-02-08	Ferrosan Ab	Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US4960776A (en) *	1987-01-28	1990-10-02	A. H. Robins Company, Inc.	4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides
WO1990013539A1 (en) *	1989-04-28	1990-11-15	Meiji Seika Kaisha, Ltd.	New n-substituted piperazine derivatives and drug for improving functional disorder of brain
FR2673182A1 (fr) *	1991-02-22	1992-08-28	Univ Caen	Piperazines n,n'-disubstituees, leur procede de preparation et leur application en therapeutique.
SE9100860D0 (sv) *	1991-03-22	1991-03-22	Kabi Pharmacia Ab	New use
SE9201239D0 (sv) *	1992-04-21	1992-04-21	Kabi Pharmacia Ab	Agents for treating substance abuse disorders
DE4219973A1 (de) *	1992-06-19	1993-12-23	Basf Ag	N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
SE9202266D0 (sv) *	1992-07-31	1992-07-31	Kabi Pharmacia Ab	Novel piperazine carboxamides
DE4307181C1 (de) *	1993-03-08	1994-11-10	Dresden Arzneimittel	Verfahren zur Herstellung von 5H-Dibenz/b,f/azepin-5-carboxamid
DE4341403A1 (de) *	1993-12-04	1995-06-08	Basf Ag	N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
JP3274579B2 (ja) *	1995-01-12	2002-04-15	住友製薬株式会社	脳血管障害に伴う精神症候治療剤
DE29815747U1 (de)	1998-09-02	2000-01-05	Ramsauer, Dieter, 42555 Velbert	Anschraubscharnier mit Raststellung
GB9923748D0 (en) *	1999-10-07	1999-12-08	Glaxo Group Ltd	Chemical compounds
USRE39921E1 (en)	1999-10-07	2007-11-13	Smithkline Beecham Corporation	Chemical compounds
GB0025354D0 (en) *	2000-10-17	2000-11-29	Glaxo Group Ltd	Chemical compounds
GB0108594D0 (en) *	2001-04-05	2001-05-23	Glaxo Group Ltd	Chemical compounds
US7157103B2 (en)	2001-08-06	2007-01-02	Euro-Celtique S.A.	Pharmaceutical formulation containing irritant
US20030044458A1 (en)	2001-08-06	2003-03-06	Curtis Wright	Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US7842307B2 (en)	2001-08-06	2010-11-30	Purdue Pharma L.P.	Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
US20030068375A1 (en)	2001-08-06	2003-04-10	Curtis Wright	Pharmaceutical formulation containing gelling agent
US7332182B2 (en)	2001-08-06	2008-02-19	Purdue Pharma L.P.	Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
US7141250B2 (en) *	2001-08-06	2006-11-28	Euro-Celtique S.A.	Pharmaceutical formulation containing bittering agent
US7482365B2 (en) *	2002-02-08	2009-01-27	Glaxo Group Limited	Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
GB0203022D0 (en) *	2002-02-08	2002-03-27	Glaxo Group Ltd	Chemical compounds
GB0203020D0 (en)	2002-02-08	2002-03-27	Glaxo Group Ltd	Chemical compounds
PL1765292T3 (pl)	2004-06-12	2018-03-30	Collegium Pharmaceutical, Inc.	Preparaty lecznicze zabezpieczające przed nadużywaniem
JP4823673B2 (ja) *	2005-12-15	2011-11-24	タカラベルモント株式会社	ショックレス弁を接続した油圧回路
JP2010169206A (ja) *	2009-01-23	2010-08-05	Finesinter Co Ltd	ノンリークショックレス電磁比例制御弁
US10668060B2 (en)	2009-12-10	2020-06-02	Collegium Pharmaceutical, Inc.	Tamper-resistant pharmaceutical compositions of opioids and other drugs
MY166034A (en)	2010-12-22	2018-05-21	Purdue Pharma Lp	Encased tamper resistant controlled release dosage forms
JP5638151B2 (ja)	2010-12-23	2014-12-10	パーデュー、ファーマ、リミテッド、パートナーシップ	不正加工抵抗性の（ｔａｍｐｅｒｒｅｓｉｓｔａｎｔ）固形経口剤形
SG11201506064UA (en)	2013-02-05	2015-08-28	Purdue Pharma Lp	Tamper resistant pharmaceutical formulations
US10751287B2 (en)	2013-03-15	2020-08-25	Purdue Pharma L.P.	Tamper resistant pharmaceutical formulations
US9737530B1 (en)	2016-06-23	2017-08-22	Collegium Pharmaceutical, Inc.	Process of making stable abuse-deterrent oral formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL137318C (sv) *	1964-06-09
JPS518283A (en) *	1974-07-09	1976-01-23	Kyorin Seiyaku Kk	11 * 33 fuenirupuropiru * 44 karubamoirupiperajinjudotaino seizoho
JPS5346988A (en) *	1976-10-07	1978-04-27	Kyorin Seiyaku Kk	Piperadine derivative

1979
- 1979-10-15 NO NO793315A patent/NO154582C/no unknown
- 1979-10-16 DE DE19792941880 patent/DE2941880A1/de active Granted
- 1979-10-18 FI FI793238A patent/FI73986C/sv not_active IP Right Cessation
- 1979-10-18 CH CH938379A patent/CH643247A5/de not_active IP Right Cessation
- 1979-10-18 FR FR7925953A patent/FR2439187A1/fr active Granted
- 1979-10-18 IT IT7926603A patent/IT1207269B/it active Protection Beyond IP Right Term
- 1979-10-18 US US06/086,068 patent/US4308387A/en not_active Expired - Lifetime
- 1979-10-19 JP JP13581779A patent/JPS5557572A/ja active Granted
- 1979-10-19 AU AU51984/79A patent/AU529260B2/en not_active Expired
- 1979-10-19 SE SE7908701A patent/SE448730B/sv not_active IP Right Cessation
- 1979-10-19 NL NLAANVRAGE7907741,A patent/NL190160C/xx not_active IP Right Cessation
- 1979-10-19 BE BE0/197737A patent/BE879528A/fr not_active IP Right Cessation
- 1979-10-19 GB GB7936297A patent/GB2037745B/en not_active Expired
- 1979-10-19 CA CA338,084A patent/CA1130807A/en not_active Expired
- 1979-10-19 LU LU81807A patent/LU81807A1/de unknown
- 1979-10-19 ES ES485188A patent/ES485188A1/es not_active Expired
- 1979-10-19 DK DK442779A patent/DK149057C/da not_active IP Right Cessation
- 1979-10-19 AT AT0683479A patent/AT376666B/de not_active IP Right Cessation
- 1979-10-19 NZ NZ191867A patent/NZ191867A/xx unknown
1981
- 1981-01-23 US US06/227,690 patent/US4385057A/en not_active Expired - Lifetime
1982
- 1982-09-15 US US06/418,685 patent/US4447433A/en not_active Expired - Lifetime
1984
- 1984-01-26 SG SG73/84A patent/SG7384G/en unknown
- 1984-07-26 HK HK571/84A patent/HK57184A/xx not_active IP Right Cessation
1994
- 1994-03-23 NL NL940004C patent/NL940004I1/nl unknown

Also Published As

Publication number	Publication date
NO793315L (no)	1980-04-22
NO154582B (no)	1986-07-28
CA1130807A (en)	1982-08-31
SG7384G (en)	1985-02-08
NO154582C (no)	1986-11-05
AU5198479A (en)	1980-06-19
FI73986C (sv)	1987-12-10
LU81807A1 (de)	1980-01-25
GB2037745A (en)	1980-07-16
JPS5557572A (en)	1980-04-28
FR2439187B1 (sv)	1983-03-18
US4447433A (en)	1984-05-08
NL7907741A (nl)	1980-04-22
DK442779A (da)	1980-04-21
AU529260B2 (en)	1983-06-02
NZ191867A (en)	1983-06-14
IT1207269B (it)	1989-05-17
US4385057A (en)	1983-05-24
JPS6326756B2 (sv)	1988-05-31
FR2439187A1 (fr)	1980-05-16
FI73986B (fi)	1987-08-31
SE448730B (sv)	1987-03-16
NL940004I1 (nl)	1994-05-02
BE879528A (fr)	1980-04-21
DK149057B (da)	1986-01-06
DK149057C (da)	1986-06-02
US4308387A (en)	1981-12-29
AT376666B (de)	1984-12-27
ATA683479A (de)	1984-05-15
NL190160C (nl)	1993-11-16
NL190160B (nl)	1993-06-16
HK57184A (en)	1984-08-03
FI793238A (fi)	1980-04-21
IT7926603A0 (it)	1979-10-18
DE2941880C2 (sv)	1989-04-20
CH643247A5 (de)	1984-05-30
DE2941880A1 (de)	1980-04-30
ES485188A1 (es)	1980-05-16
GB2037745B (en)	1982-11-24

Legal Events

Date

Code

Title

Description

1995-01-31

NAL

Patent in force

Ref document number: 7908701-1

Format of ref document f/p: F

2000-01-10

NUG

Patent has lapsed